Franklin Resources’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.6M Sell
132,031
-69,610
-35% -$20.5M 0.01% 769
2026
Q1
$59.9M Buy
201,641
+107,047
+113% +$34.7M 0.01% 593
2025
Q4
$28.7M Buy
94,594
+52,627
+125% +$17.2M 0.01% 837
2025
Q3
$14.3M Buy
41,967
+25,713
+158% +$7.81M ﹤0.01% 1060
2025
Q2
$3.93M Buy
16,254
+15,373
+1,745% +$3.77M ﹤0.01% 1454
2025
Q1
$240K Buy
+881
New +$206K ﹤0.01% 2595
2022
Q4
Sell
-2,767
Closed -$374K 2397
2022
Q3
$374K Buy
2,767
+233
+9% +$40K ﹤0.01% 1774
2022
Q2
$410K Buy
2,534
+42
+2% +$6.56K ﹤0.01% 1764
2022
Q1
$470K Sell
2,492
-30
-1% -$6.38K ﹤0.01% 1858
2021
Q4
$684K Sell
2,522
-159
-6% -$53.7K ﹤0.01% 1790
2021
Q3
$973K Buy
2,681
+1,833
+216% +$599K ﹤0.01% 1643
2021
Q2
$291K Buy
848
+17
+2% +$5.63K ﹤0.01% 1734
2021
Q1
$289K Sell
831
-5,374
-87% -$1.78M ﹤0.01% 1714
2020
Q4
$1.6M Buy
6,205
+5,071
+447% +$1.4M ﹤0.01% 1333
2020
Q3
$325K Buy
+1,134
New +$267K ﹤0.01% 1567

Other funds holding ONC

Franklin Resources's ONC Position: Q2 2026 in Review

Franklin Resources reduced its BeOne Medicines Ltd (ONC) stake by 35% in Q2 2026, selling an estimated $20.5M and leaving 132,031 shares worth $37.6M. The position accounts for 0.01% of the portfolio, ranked #769.

Franklin Resources first reported a position in ONC in Q3 2020 and has held it in 15 quarters since. The position peaked at $59.9M in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Franklin Resources held 132,031 shares of BeOne Medicines Ltd worth $37.6M as of Q2 2026.
  • Franklin Resources sold 69,610 BeOne Medicines Ltd shares in Q2 2026, an estimated $20.5M.
  • BeOne Medicines Ltd made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #769 holding.
  • Franklin Resources first reported a position in BeOne Medicines Ltd in Q3 2020 and has held it in 15 quarters since.
  • Franklin Resources's BeOne Medicines Ltd position peaked at $59.9M in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.